Find out more about the work we do here.
Past event that saw the largest ever Korean biopharma delegation visit the UK to discuss collaboration opportunities.
Angels in MedCity alumnus raises £12.3m
Angels in MedCity alumnus Sense Biodetection has raised £12.3M to develop a portfolio of instrument-free, point-of care molecular diagnostic tests.
Representing the UK in Japan
Find out more about the ten companies from around the UK that joined us at BioJapan 2019.
Select Committee Report
Report highlights importance of reaching R&D spending targets.
MedCity signs agreement with South Korea
MedCity continues work to strengthen ties between our region and networks from the sector around the world.
The UK landscape for Digital Therapeutics
Where we are and what is to come.